Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Goëb

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Rheumatology|June 8, 2006
Management of infusion reactions to infliximab in patients with rheumatoid arthritis or spondyloarthritis: experience from an immunotherapy unit of rheumatologyThierry Lequerré, Olivier Vittecoq, Nathalie Klemmer, et al.
Annals of the Rheumatic Diseases|October 23, 2012
Progression to rheumatoid arthritis in early inflammatory arthritis is associated with low IL-7 serum levelsVincent Goëb, Philippe Aegerter, Rekha Parmar, et al.
Arthritis Research & Therapy|December 24, 2014
Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritisSarah M Churchman, Jehan J El-Jawhari, Agata N Burska, et al.
European Geriatric Medicine|April 26, 2025
Immediate risk factors for fracture recurrence after initial fractures, based on fracture liaison service dataset, and comparison with fall risk factors reported in the literatureMarie Doussiere, Yannis Hamidou, Vanessa Moukarzel, et al.
Arthritis Research & Therapy|March 17, 2009
Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymesVincent Goëb, Marlène Thomas-L'Otellier, Romain Daveau, et al.
Journal of Clinical and Translational Research|April 10, 2023
Current characteristics of a population of psoriatic arthritis and gender disparitiesJimmy Menis, Marie Doussiere, Estelle Touboul, et al.
Arthritis Research & Therapy|February 11, 2017
Th17 and CD24<sup>hi</sup>CD27<sup>+</sup> regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritisSarah Salomon, Caroline Guignant, Pierre Morel, et al.
Joint Bone Spine|October 2, 2012
Efficacy of anti-TNF in patients with spondyloarthritis in absence of any imaging signAurélia Bisson-Vaivre, Didier Alcaix, Charles Zarnitsky, et al.
Journal of Clinical Medicine|June 26, 2026
Relevance of Systematic Pre-Biologic Infectious Screening in Chronic Inflammatory Rheumatic Diseases: A Retrospective Single-Center StudyMarie Doussiere, Clémence Jouret, Lara Awad, et al.
Joint Bone Spine|July 22, 2010
A 3 mg/kg starting dose of infliximab in active spondyloarthritis resistant to conventional treatments is efficient, safe and lowers costsGinette Tenga, Vincent Goëb, Thierry Lequerré, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Rheumatology|June 8, 2006
Management of infusion reactions to infliximab in patients with rheumatoid arthritis or spondyloarthritis: experience from an immunotherapy unit of rheumatologyThierry Lequerré, Olivier Vittecoq, Nathalie Klemmer, et al.
Annals of the Rheumatic Diseases|October 23, 2012
Progression to rheumatoid arthritis in early inflammatory arthritis is associated with low IL-7 serum levelsVincent Goëb, Philippe Aegerter, Rekha Parmar, et al.
Arthritis Research & Therapy|December 24, 2014
Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritisSarah M Churchman, Jehan J El-Jawhari, Agata N Burska, et al.
European Geriatric Medicine|April 26, 2025
Immediate risk factors for fracture recurrence after initial fractures, based on fracture liaison service dataset, and comparison with fall risk factors reported in the literatureMarie Doussiere, Yannis Hamidou, Vanessa Moukarzel, et al.
Arthritis Research & Therapy|March 17, 2009
Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymesVincent Goëb, Marlène Thomas-L'Otellier, Romain Daveau, et al.
Journal of Clinical and Translational Research|April 10, 2023
Current characteristics of a population of psoriatic arthritis and gender disparitiesJimmy Menis, Marie Doussiere, Estelle Touboul, et al.
Arthritis Research & Therapy|February 11, 2017
Th17 and CD24<sup>hi</sup>CD27<sup>+</sup> regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritisSarah Salomon, Caroline Guignant, Pierre Morel, et al.
Joint Bone Spine|October 2, 2012
Efficacy of anti-TNF in patients with spondyloarthritis in absence of any imaging signAurélia Bisson-Vaivre, Didier Alcaix, Charles Zarnitsky, et al.
Journal of Clinical Medicine|June 26, 2026
Relevance of Systematic Pre-Biologic Infectious Screening in Chronic Inflammatory Rheumatic Diseases: A Retrospective Single-Center StudyMarie Doussiere, Clémence Jouret, Lara Awad, et al.
Joint Bone Spine|July 22, 2010
A 3 mg/kg starting dose of infliximab in active spondyloarthritis resistant to conventional treatments is efficient, safe and lowers costsGinette Tenga, Vincent Goëb, Thierry Lequerré, et al.
Pageof 7